Lacrofarm (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

The active ingredients—sodium hydrogen carbonate, potassium chloride, sodium chloride, and macrogol 3350—act as osmotic agents. They draw water into the intestinal lumen, softening fecal matter and stimulating peristalsis, which together facilitate bowel movements without significant systemic absorption.

The appropriate dose of Lacrofarm is determined by the prescribing healthcare professional based on the patient’s condition, age, and response to therapy. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Safety of Lacrofarm in pregnancy or lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this medication.

To order Lacrofarm, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with stimulant laxatives, Lacrofarm’s osmotic mechanism generally produces softer stools and carries a lower risk of cramping. Unlike bulk‑forming agents, it does not rely on dietary fiber and works quickly by drawing water into the bowel, making it suitable for rapid bowel preparation.

Lacrofarm should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Lacrofarm is taken orally, usually as a liquid or powder that is dissolved in water according to the prescriber’s instructions. It should be consumed with a full glass of water and may be taken with or without food, depending on the specific guidance provided.

Serious risks include severe electrolyte disturbances, dehydration, and rare allergic reactions such as rash, itching, or anaphylaxis. Patients should seek immediate medical attention if they experience symptoms like rapid heartbeat, muscle weakness, severe abdominal pain, or signs of an allergic response.

Lacrofarm should be avoided in individuals with known hypersensitivity to any of its components, in patients with intestinal obstruction, severe renal impairment, or uncontrolled electrolyte imbalances. It is also contraindicated in those who have recently undergone bowel surgery without medical advice.